Current location:business >>
Prostate cancer breakthrough means thousands of men could avoid devastating chemotherapy
business7488People have gathered around
IntroductionThousands of men a year with advanced prostate cancer could avoid gruelling chemotherapy by combinin ...
Thousands of men a year with advanced prostate cancer could avoid gruelling chemotherapy by combining radiotherapy and hormone therapy, a study reveals.
Targeting the radiotherapy to the sites where the cancer has spread can delay further progression of the disease and the need for subsequent treatments, such as chemotherapy, which can have significant impact on a person's quality of life, researchers say.
The trial demonstrated that the patients' cancer did not progress for an average of six months (6.4) and two fifths (40.1 per cent) of patients remained progression-free at 12 months.
The research was led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, and presented today at The European Society for Radiotherapy and Oncology (ESTRO) annual congress.
The Phase II trial is the first prospective trial to investigate the use of stereotactic body radiotherapy (SBRT) in patients with hormone-resisistant oligoprogressive prostate cancer.
Targeting the radiotherapy to the sites where the cancer has spread can delay further progression of the disease and the need for subsequent treatments, such as chemotherapy, which can have significant impact on a person's quality of life, researchers say
Oligoprogressive cancer occurs when cells from the original tumour travel within the body to fewer than three sites, forming new tumours or lesions.
Currently, disease progression after hormone therapy treatment is taken as a sign that the cancer has become resistant to the treatment.
However, findings from the trial revealed that it may just be some tumours that are resistant, and if the tumours are treated with radiotherapy the rest of the cancer will still respond to hormone therapy.
In the national study, which took place in cancer centres across the UK, researchers investigated whether giving SBRT along with a type of hormone therapy, called androgen receptor targeted agents, to patients with oligoprogressive prostate cancer would delay the time it takes for their cancer to progress.
The patients in the study had advanced prostate cancer that was no longer responding to regular treatment.
More than 52,000 men are diagnosed with prostate cancer every year on average in the UK, making it the most common cancer in men. Around 12,000 men die every year from the disease — the equivalent of one every 45 minutes
They had no more than two new areas of cancer that had appeared while they were on two types of hormone therapy, after initially responding well to the treatment.
All the patients were treated with five or six treatments SBRT, which is painless and takes about 20-30 minutes for each treatment.
81 men received SBRT and most of them (67 per cent) had one oligoprogressive lesion. The areas treated were bone (59 per cent), lung (1 per cent), lymph node (32 per cent) and prostate (8 per cent).
At an average of 19.2 months, 53 (65 per cent) patients experienced progression of their disease; 32 (40 per cent) progressed within six months following SBRT treatment.
Median progression-free survival following SBRT was 6.4 months and 40 per cent of men had no evidence of cancer growth 12 months after treatment.
Researchers estimate around 2,000 to 3,000 men per year would meet the qualifying criteria above.
WHAT IS PROSTATE CANCER?
How many people does it kill?
More than 11,800 men a year - or one every 45 minutes - are killed by the disease in Britain, compared with about 11,400 women dying of breast cancer.
It means prostate cancer is behind only lung and bowel in terms of how many people it kills in Britain.
In the US, the disease kills 26,000 men each year.
Despite this, it receives less than half the research funding of breast cancer and treatments for the disease are trailing at least a decade behind.
How many men are diagnosed annually?
Every year, upwards of 52,300 men are diagnosed with prostate cancer in the UK - more than 140 every day.
How quickly does it develop?
Prostate cancer usually develops slowly, so there may be no signs someone has it for many years, according to the NHS.
If the cancer is at an early stage and not causing symptoms, a policy of 'watchful waiting' or 'active surveillance' may be adopted.
Some patients can be cured if the disease is treated in the early stages.
But if it is diagnosed at a later stage, when it has spread, then it becomes terminal and treatment revolves around relieving symptoms.
Thousands of men are put off seeking a diagnosis because of the known side effects from treatment, including erectile dysfunction.
Tests and treatment
Tests for prostate cancer are haphazard, with accurate tools only just beginning to emerge.
There is no national prostate screening programme as for years the tests have been too inaccurate.
Doctors struggle to distinguish between aggressive and less serious tumours, making it hard to decide on treatment.
Men over 50 are eligible for a ‘PSA’ blood test which gives doctors a rough idea of whether a patient is at risk.
But it is unreliable. Patients who get a positive result are usually given a biopsy which is also not fool-proof.
Scientists are unsure as to what causes prostate cancer, but age, obesity and a lack of exercise are known risks.
Anyone with any concerns can speak to Prostate Cancer UK's specialist nurses on 0800 074 8383 or visit prostatecanceruk.org
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Global Grandeur news portal”。http://lesotho.brianlynch.org/article-53e199754.html
Related articles
I tried Hollywood's hottest fitness class loved by Jennifer Aniston and Michelle Obama
businessIf, as influencers like to say, life happens outside your comfort zone, I had already done a lot of ...
【business】
Read moreJohn Goodman, 71, shows off his slimmed
businessJohn Goodman displayed his 200lb weight loss as he arrived at John F. Kennedy airport in New York wi ...
【business】
Read moreNetflix fans are left STUNNED by the streaming site's 'most UNHINGED' show yet
businessNetflix fans have been left stunned by the streaming site's 'most unhinged show' yet.The TV show Unl ...
【business】
Read more
Popular articles
- RuPaul's Drag Race Australia judge Rhys Nicholson lists unique Coburg townhouse for $850K
- OJ Simpson dead at 76 after cancer battle: Football legend turned accused double
- Police build a case against Lego gang: Thieves steal $300,000 worth of high
- Lionel Richie reveals being selected as performer at King Charles Coronation Concert was 'surprise'
- China's trade with other BRICS members up 11.3 pct in Q1
- Seafood shocker: Warning shrimp and lobster contain dangerous levels of cancer
Latest articles
Rihanna goes 'nude' as she models a lacy body suit in a video promoting her new lingerie collection
16,000 SQ FT home in Montana goes on sale for just $10
Father of teen stabbed to death on Apple River by knife
EMMA COWING: A precious glimpse into the Queen's happy home
Donald Trump calls Joe Biden weak on antisemitism, ignoring his own rhetoric
Amanda Bynes' former Nickelodeon co
LINKS
- Hundreds of bulbs, entire rose bushes stolen from Christchurch park
- US court blocks strict new immigration law in Texas
- Israeli hostages' relatives arrested at protest as Gaza talks break down
- US call at UN for Gaza truce linked to hostages blocked
- Kāinga Ora cans controversial social housing development, saying it is not financially viable
- Auckland lodge fire: Caravan user forced to stick to one set of clothes
- Kaimanawa wild horses: Group re
- Woman's death after electric blanket fire triggers warning from Coroner
- 'We can sue him': Chumbawamba on Winston Peters use of their song
- Man accused of Ellerslie murder named